Modalis Therapeutics Corp
TSE:4883
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Modalis Therapeutics Corp
TSE:4883
|
JP |
|
A
|
Archer Materials Ltd
OTC:ARRXF
|
AU |
|
D
|
Daechang Solution Co Ltd
KOSDAQ:096350
|
KR |
|
LG Corp
KRX:003550
|
KR |
|
P
|
Pan Asia Environmental Protection Group Ltd
HKEX:556
|
HK |
Intrinsic Value
Is Modalis Therapeutics Corp undervalued or overvalued?
See the intrinsic value estimate for Modalis Therapeutics Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Modalis Therapeutics Corp looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Modalis Therapeutics Corp’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Modalis Therapeutics Does
Modalis Therapeutics is a biotechnology company that develops medicines based on gene editing and gene regulation. Its main work is to build treatment programs for diseases where changing how a gene works could address the underlying cause, rather than just easing symptoms. The company’s customers are mainly drug developers, research partners, and ultimately patients through approved therapies if its programs succeed.
- Headquarters
- Japan JP
- Employees
- 17
- IPO date
- Aug 3, 2020
Earnings Waterfall
Modalis Therapeutics Corp
The intrinsic value for Modalis Therapeutics Corp (4883) under the Base Case is hidden JPY.
Compared with the current market price of 27 JPY, the stock appears hidden.